Study shows targeting DDX3 with RK-33 reduced the viral load in four isolates of SARS-CoV-2

A new study has focused on developing a novel anti-SARS-CoV-2 therapy using HTA directed against the human host DEAD-box RNA helicase.

Related Keywords

,Drug Administration ,Respiratory Syncytial ,West Nile ,Components Analysis ,Coronavirus Disease Covid 19 ,Cars ,Ars Cov 2 ,Compound ,Coronavirus ,Covid 19 ,Wood ,Enome ,Enomic ,Helicase ,Olecule ,Pandemic ,Protein ,Espiratory ,Na ,Evere Acute Respiratory ,Evere Acute Respiratory Syndrome ,Spike Protein ,Yndrome ,Translation ,Vaccine ,Virus ,